Page last updated: 2024-10-26

dipyridamole and Fever

dipyridamole has been researched along with Fever in 4 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Fever: An abnormal elevation of body temperature, usually as a result of a pathologic process.

Research Excerpts

ExcerptRelevanceReference
"A clinical diagnosis of thrombotic thrombocytopenic purpura (TTP) was made."1.30A case of dermatomyositis complicated by thrombotic thrombocytopenic purpura. ( Arase, S; Horie, T; Miyaoka, Y; Nameda, Y; Sano, N; Shigekiyo, T; Urano, Y, 1997)
"The diagnosis of Kawasaki disease and echocardiographic evaluation of the coronary arteries should be considered in young infants with prolonged fever of unknown origin."1.27Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. ( Burns, JC; Glodé, MP; Leung, DY; Newburger, JW; Toews, WH; Wiggins, JW; Wilson, H, 1986)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miyaoka, Y1
Urano, Y1
Nameda, Y1
Shigekiyo, T1
Horie, T1
Sano, N1
Arase, S1
Oshima, T1
Burns, JC1
Wiggins, JW1
Toews, WH1
Newburger, JW1
Leung, DY1
Wilson, H1
Glodé, MP1
Haan, J1
Penzhorn, H1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
[NCT00000520]Phase 20 participants Interventional1985-07-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

4 other studies available for dipyridamole and Fever

ArticleYear
A case of dermatomyositis complicated by thrombotic thrombocytopenic purpura.
    Dermatology (Basel, Switzerland), 1997, Volume: 194, Issue:1

    Topics: Anti-Inflammatory Agents; Dermatomyositis; Dipyridamole; Dyspnea; Epoprostenol; Fatal Outcome; Fever

1997
[Predictive factors for development of hemolytic uremic syndrome (HUS) and early intensive treatments for prevention of HUS enterohemorrhagic Escherichia coli infection].
    The Japanese journal of antibiotics, 1997, Volume: 50, Issue:11

    Topics: Abdominal Pain; Adolescent; Age Factors; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroi

1997
Clinical spectrum of Kawasaki disease in infants younger than 6 months of age.
    The Journal of pediatrics, 1986, Volume: 109, Issue:5

    Topics: Aspirin; Coronary Aneurysm; Dipyridamole; Drug Therapy, Combination; Echocardiography; Electrocardio

1986
[Temperature and fever reducing properties of 2,6-bis(diethanolamino)--4,8-dipiperidino-pyrimido(5,4-d)pyrimidine (dipyridamol) in rabbits].
    Arzneimittel-Forschung, 1968, Volume: 18, Issue:6

    Topics: Animals; Body Temperature; Depression, Chemical; Dipyridamole; Female; Fever; Heart Rate; Lipopolysa

1968